Technical Analysis for JANX - Janux Therapeutics, Inc.

Grade Last Price % Change Price Change
B 33.9 4.53% 1.47
JANX closed up 4.53 percent on Monday, August 2, 2021, on 17 percent of normal volume. Note that the stock is in overbought territory based on its Slow Stochastic indicator (14, 3, 3) -- sideways movement or a pullback should not be unexpected.

Trend Table & Recent EOD Trading Signals

ADX Long Term Intermediate Term Short Term
Weak or Absent N/A N/A Up
Historical JANX trend table...

Date Alert Name Type % Chg
New 52 Week Closing High Bullish 0.00%
Upper Bollinger Band Walk Strength 0.00%
Above Upper BB Strength 0.00%
Overbought Stochastic Strength 0.00%
Up 3 Days in a Row Strength 0.00%
Up 4 Days in a Row Strength 0.00%
Upper Bollinger Band Touch Strength 0.00%
New 52 Week Closing High Bullish 4.53%
Stochastic Reached Overbought Strength 4.53%
Upper Bollinger Band Walk Strength 4.53%
Older End-of-Day Signals for JANX ...

   Recent Intraday Alerts -- Get these alerts pushed to you via our Mobile App

Alert Time
Up 5% about 11 hours ago
Up 3% about 12 hours ago
60 Minute Opening Range Breakout about 14 hours ago
Up 2% about 14 hours ago
Rose Above Previous Day's High about 15 hours ago
View Earlier Intraday Alerts

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.

Profile

Janux Therapeutics, Inc., a biopharmaceutical company, develops therapeutics based on proprietary Tumor Activated T Cell Engager (TRACTr) platform technology to treat patients suffering from cancer. The company's lead TRACTr product candidates that are in preclinical or discovery stage target prostate-specific membrane antigen, epidermal growth factor receptor, and trophoblast cell surface antigen 2. It is also developing a Tumor Activated Immunomodulator (TRACIr) costimulatory bispecific product candidate against programmed death-ligand 1 and CD28 designed to improve the anti-tumor activity of T cells. The company was incorporated in 2017 and is headquartered in La Jolla, California.
Classification

Sector: Healthcare
Industry: Biotechnology
Keywords: Medicine Biopharmaceutical Cancer Clinical Medicine Immunology Immune System Tumor Platform Technology Chimeric Antigen Receptor T Cell T Cell Clusters Of Differentiation

Is JANX a Buy, Sell or Hold?

Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength

Indicators

Indicator Value
52 Week High 37.99
52 Week Low 16.32
Average Volume 284,192
200-Day Moving Average 0.00
50-Day Moving Average 0.00
20-Day Moving Average 28.41
10-Day Moving Average 29.94
Average True Range 2.22
ADX 11.22
+DI 29.48
-DI 15.14
Chandelier Exit (Long, 3 ATRs) 27.48
Chandelier Exit (Short, 3 ATRs) 29.44
Upper Bollinger Bands 32.63
Lower Bollinger Band 24.19
Percent B (%b) 1.15
BandWidth 29.71
MACD Line 2.29
MACD Signal Line 1.99
MACD Histogram 0.3049
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 37.71
Resistance 3 (R3) 37.37 35.76 37.08
Resistance 2 (R2) 35.76 34.79 35.93 36.86
Resistance 1 (R1) 34.83 34.19 35.30 35.17 36.65
Pivot Point 33.22 33.22 33.45 33.39 33.22
Support 1 (S1) 32.29 32.25 32.76 32.63 31.15
Support 2 (S2) 30.68 31.65 30.85 30.94
Support 3 (S3) 29.75 30.68 30.73
Support 4 (S4) 30.09